ST
Shattuck Labs, Inc.
STTK · NASDAQ
$5.86 -9.85% (-$0.64)
1M +0.00%
Market Cap $587.4M
P/E Ratio -
Div. Yield -
ROE 43.57%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
35 /100
Fair P/S 587.42x
P/B 2.78x
P/E N/A
Growth
69 /100
Growing Rev. growth 15.32%
Book val. growth 22.38%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 750.90%
FCF margin 4,124.00%
Net margin 5,256.80%
Quality
0 /100
Poor ROIC 26.09%
Asset turnover 0.00x
ROE 43.57%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 27.59x
Int. coverage N/A
Stability
46 /100
Moderate Beta 1.10x
Profitable years 0
Rev. volatility 169.19%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about STTK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Taylor H. Schreiber
Employees
40
Headquarters
Austin
Upcoming events
10 NOV
Earnings
Upcoming earnings report